QuidelOrtho Corporation
QDEL
QuidelOrtho Corporation focuses on the development and manufacture of diagnostic testing technologies across the continuum of healthcare testing needs. The company operates through Labs, Transfusion Medicine, Point-of-Care, and Molecular Diagnostics business units. The Labs business unit provides clinical chemistry laboratory instruments and tests that measure target chemicals in bodily fluids forā¦ read more
Healthcare
Medical Instruments & Supplies
34 years
USD
Exclusive to Premium users
Price
per share adjusted in USD$33.69
Price+0.54%
$0.18
1Y
Price
Market Cap
$2.289b
Mid
Price/Earnings 3y Avg5y Avg
-
Premium
Premium
Financial Reports
Key metrics over the past few years and other important metrics. Amounts in USD.-85.5%
EBITDA Margin-104.7%
Net Profit Margin-13.5%
Free Cash Flow Margin-85.5%
EBITDA Margin-104.7%
Net Profit Margin-13.5%
Free Cash Flow MarginRevenue
$2.716b
-2.4%
1y CAGR-5.9%
3y CAGR+18.6%
5y CAGREarnings
-$1.179b
+42.5%
1y CAGR-6758.7%
3y CAGR-5074.6%
5y CAGREPS
-$17.02
+44.3%
1y CAGR-6772.4%
3y CAGR-5089.8%
5y CAGRBook Value
$2.036b
$5.675b
Assets$3.639b
Liabilities$2.844b
DebtDebt to Assets
50.1%
-5.5x
Debt to EBITDAFree Cash Flow
-$42.800m
+61.8%
1y CAGR-95.6%
3y CAGR-60.4%
5y CAGRNo items found.
Press Releases
Statements and updates from the company